Fioretti, Bernard, Tiziana Pietrangelo, Luigi Catacuzzeno, and Fabio Franciolini. Intermediate-conductance Ca 2ϩ -activated K ϩ channel is expressed in C2C12 myoblasts and is downregulated during myogenesis.
-activated K ϩ (IKCa) channel. The IKCa current, recorded under perforated-patch configuration, had a transient time course when activated by ionomycin (0.5 M; peak current density 26.2 Ϯ 3.7 pA/pF; n ϭ 10), but ionomycin (0.5 M) ϩ 5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one (100 M) evoked a stable outward current (28.4 Ϯ 8.2 pA/pF; n ϭ 11). The current was fully inhibited by charybdotoxin (200 nM), clotrimazole (2 M), and 5-nitro-2-(3-phenylpropylamino)benzoic acid (300 M), but not by tetraethylammonium (1 mM) or D-tubocurarine (300 M). Congruent with the IKCa channel, elevation of intracellular Ca 2ϩ in inside-out patches resulted in the activation of a voltage-insensitive K ϩ channel with weak inward rectification, a unitary conductance of 38 Ϯ 6 pS (at negative voltages), and an IC50 for Ca 2ϩ of 530 nM. The IKCa channel was activated metabotropically by external application of ATP (100 M), an intracellular Ca 2ϩ mobilizer. Under current-clamp conditions, ATP application resulted in a membrane hyperpolarization of ϳ35 mV. The IKCa current downregulated during myogenesis, ceasing to be detectable 4 days after the myoblasts were placed in differentiating medium. Downregulation was prevented by the myogenic suppressor agent basic FGF (bFGF). We also found that block of the IK Ca channel by charybdotoxin did not inhibit bFGF-sustained myoblast proliferation. These observations show that in C 2C12 myoblasts the IK Ca channel expression correlates inversely with differentiation, yet it does not appear to have a role in myoblast proliferation.
ATP; cell proliferation
MYOGENESIS IS A HIGHLY REGULATED process during which proliferating myoblasts withdraw from the cell cycle and fuse to form an ordered array of large, multinucleated muscle fibers that express specific proteins (34) . C 2 C 12 myoblasts (2, 37) represent a myogenic cell line that has been widely used as an in vitro model of myogenesis for a variety of biochemical and physiopathological studies (19, 38) . When cultured with a high serum concentration, C 2 C 12 myoblasts remain in the myoblast state while continuing to proliferate. On serum withdrawal, these cells arrest proliferation and begin differentiating. Ion channels are centrally involved in this process, with several types being either upregulated or downregulated during the complex steps leading to differentiated muscle fibers (1) . Proliferating C 2 C 12 myoblasts express an ATP-induced K ϩ (K ATP ) current, and a swelling-activated Cl Ϫ current (I Cl,sw ) (14, 33) . During myogenesis the K ATP current and I Cl,sw disappear and other currents appear, such as the TTX-sensitive Na ϩ current, the delayed-rectifier K ϩ (DRK) current, the inward-rectifier K ϩ (K ir ) current, and the L-type Ca 2ϩ (Ca L ) currents (14, 15, 33, 35 (3, 10, 11, 32) . The IK Ca channels (K Ca 3.1; Ref. 7) have a distinct pharmacological profile, being blocked by the scorpion venom toxin charybdotoxin (CTX) and the antifungal imidazole compound clotrimazole (CTL) but resistant to tetraethylammonium (TEA) and D-tubocurarine (D-TC), effective blockers of BK Ca channels and of two of the three subtypes (SK2 and SK3) of SK Ca channels, respectively (3, 32) . These biophysical and pharmacological properties were used to identify the IK Ca current in C 2 C 12 myoblasts. The IK Ca channel was previously shown to be expressed in the myogenic mesodermal stem cell line C3H10T1/2 expressing the myogenic regulatory factor 4 (MRF4) (C3H10T1/2-MRF4), required for complete myogenic differentiation (24, 25) . In this cell line, the upregulation of IK Ca channels sustained by basic FGF (bFGF) was shown to prevent myogenic differentiation while maintaining proliferation (24 -26) . The results presented here show that the IK Ca channel is abundantly expressed in C 2 C 12 myoblasts and is downregulated during myogenesis. Unlike the C3H10T1/2-MRF4 cell line, the IK Ca channel in C 2 C 12 myoblasts was not required for proliferation. The IK Ca channel may thus represent a marker for undifferentiated C 2 C 12 myoblasts.
METHODS
Cell culture. The murine skeletal myoblast cell line C2C12 (at passages [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] was obtained from the American Type Culture Collection (ATCC, Rockville, MD; CRL 1772). C 2C12 proliferating myoblasts, plated at 2,000 cells/cm 2 , were maintained in a humidified atmosphere (CO2 5%-air 95%, 37°C) and passaged by standard trypsinization every 3 days (27) in a growth medium (GM) consisting of DMEM supplemented with 20% fetal bovine serum, 4 mM Lglutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin (GIBCO BRL, Gaithersburg, MD). For differentiation-committed cells, cells were plated at 6,000/cm 2 directly in differentiation medium (DM) consisting of DMEM supplemented with 2% horse serum (HS), 4 mM L-glutamine, 100 IU/ml penicillin and 100 g/ml streptomycin (GIBCO). The experiments were carried out both on proliferating myoblasts at days 1-4 after being plated in either GM or bFGF (EuroClone) and on differentiation-committed cells at days 1-4 after plating in DM.
Electrophysiology. Whole cell (perforated), cell-attached, and inside-out patch-clamp configurations were used for electrophysiological recordings on C 2C12 myoblasts. Electrode resistance was 3-5 M⍀ for whole cell experiments and 5-10 M⍀ for cell-attached and inside-out experiments. Single-channel and whole cell currents were amplified with a List EPC-7 amplifier (List Medical, Darmstadt, Germany), and digitized with a 12-bit analog-to-digital converter (TL-1, DMA interface; Axon Instruments, Foster City, CA). The pCLAMP software package (version 7.0; Axon Instruments) was used. For online data collection, macroscopic and single-channel currents were filtered at 5 and 0.5 kHz and sampled at 20 and 200 s/point, respectively. Membrane capacitance (C m) measurements were made by using the Membrane Test routine of the pCLAMP software. Whole cell currents were routinely expressed as current densities (pA/pF) calculated with respect to the measured cell Cm. In cell-attached experiments the membrane potential (Vm,patch) sensed by the patch results from the sum of the applied (pipette) potential and the cell membrane potential (Vm,patch ϭ Vpipette ϩ Vm,cell). During the ATP response, Vm,cell was estimated to reach and remain stable for 5-20 s at about Ϫ60 mV (cf. Fig. 4, D and E) . The Na ϩ -to-K ϩ permeability ratio (PNa/PK) for single IKCa channels, bathed in 150 mM internal Na ϩ and 150 mM external K ϩ solutions, was assessed with the Goldman-Hodgkin-Huxley (GHK) relationship PNa/PK ϭ exp(RT/ErevF), where Erev is the single-channel current reversal potential and R, T, and F are the gas constant, temperature, and Faraday constant, respectively (8) . Experiments were carried out at room temperature (RT; 18 -22°C), and the resulting data are presented as means Ϯ SE.
Solutions and drugs. Macroscopic currents were recorded with the perforated-patch method. With this configuration the bathing physiological salt solution (PSS) contained (in mM) 106.5 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 5 MOPS, 20 glucose, and 30 Na-gluconate at pH 7.25, and the pipette solution contained (in mM) 57.5 K2SO4, 55 KCl, 5 MgCl2, and 10 MOPS at pH 7.2. Electrical access to the cytoplasm was achieved by adding amphotericin B (200 M) to the pipette solution. Access resistances in the range of 10 -20 M⍀ were achieved within 10 min after seal formation. In cell-attached recordings the bathing solution contained (in mM) 106.5 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 5 MOPS, 20 glucose, and 30 Na-gluconate at pH 7.25, and the pipette solution contained (in mM) 150 KCl, 2 CaCl2, 2 MgCl2, 5 MOPS, and 10 glucose at pH 7.4. In inside-out single-channel recordings the bathing solution contained (in mM) 150 KCl (NaCl), 1 EGTA-K (EGTA-Na), 5 MOPS, and 1 MgCl2, pH 7.2 at the indicated free Ca 2ϩ concentration, and the pipette solution contained (in mM) 150 KCl, 2 CaCl2, 2 MgCl2, 5 MOPS, and 10 glucose, pH 7.4. All chemicals used were of analytical grade. DMSO, TEA, D-TC, and CTL were purchased from Sigma (St. Louis, MO). CTX was purchased from Alomone Labs (Jerusalem, Israel). We routinely used CTL because of its greater selectivity toward IKCa channels compared with other Ca 2ϩ -activated K ϩ channels. In practice, however, the experiments were usually repeated with CTX. In contrast, in the proliferation assay we only used CTX, because preliminary experiments showed that CTL had toxic actions. Ionomycin, 5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one (DCEBIO), and 5-nitro-2-(3-phenylpropylamino)benzoic acid (NPPB) were purchased from Tocris Cookson (Bristol, UK). CTL, NPPB, DCEBIO, ionomycin, and amphotericin B were similarly dissolved in stock solutions with DMSO to concentrations of 20, 100, 100, 1, and 50 mM, respectively. Pharmacological agents were dissolved daily in the appropriate solution at the concentrations stated and were bath applied by gravity-fed superfusion at a flow rate of 2 ml/min, with complete solution exchange within the recording chamber in ϳ1 min. The maximal DMSO concentration in the recording solution was ϳ1%. ATP was applied with a Picospritzer II (General Valve, Fairfield, NJ) via a glass pipette with tip diameter about twice as large as that used for whole cell recording. The glass pipette was normally placed within 40 m of the patched cell to accelerate the increase in drug concentration at the cell, and to allow brief application times to minimize desensitization of the ATP response or IK Ca channel rundown.
Cell proliferation assays. C 2C12 myoblasts were seeded at 3,000 cells/cm and held for 5 h in a synchronization medium containing low-glucose DMEM supplemented with 2% HS, plus 4 mM Lglutamine, 100 IU/ml penicillin, and 100 g/ml streptomycin (DM).
As assessed by cytofluorimetric analysis, under this condition the cell cycle distribution was: G 0/G1 82 Ϯ 7% and G2/S 15 Ϯ 5% (n ϭ 2). Myoblasts were then stimulated with 200 nM CTX, 20 ng/ml bFGF, or 20 ng/ml bFGF in combination with either 200 nM CTX or the src kinase inhibitor PP-2 at 50 M. PP-2 was dissolved in DMSO. As control, we verified that DMSO, applied to myoblasts at the same concentration used in our experiments, did not significantly interfere with C 2C12 growth. CTX and PP-2 were added 2-5 min and 15 min, respectively, before bFGF addition. Cell proliferation was assessed by both 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) and bromodeoxyuridine (BrdU) incorporation assays. The MTT assay was carried out by incubating the cells for 3 h with 5 mg/ml MTT and solubilizing the tetrazolium salts precipitated on the cells with 200 l of DMSO for 30 min (23). The absorbance was read on a Titertek Multiscan Microelisa reader (Flow Laboratories). We considered 16 wells for treatment and repeated the experiments twice. BrdU incorporation assay was performed by treating the cells with 50 M BrdU (Sigma). Coverslips were then washed with PBS, and the cells were fixed with 95% ethanol for 5 min at RT. Cells were then treated with 2 M HCl for 1 min at RT, washed with PBS, and maintained for 1 h in 10% normal goat serum (NGS) plus 0.2% Triton X-100 in PBS. The cells were then incubated with 1:100 monoclonal mouse anti-BrdU (DAKO) in 10% NGS in PBS for 90 min at 37°C. Cells were then subjected to three washes with PBS for 5 min each at RT and incubation with 1:200 anti-mouse secondary antibody (mouse immunoglobulin biotin, DAKO no. E0354) in PBS for 40 min at RT. After three washes with PBS for 5 min each at RT, we amplified the signal by incubating with AB complex for 45 min (StreptABComplex/ HRP, no. K0377, DAKO). After 2 washes with PBS, we revealed the staining with diaminobenzidine and H2O2, per kit directions. The pictures of the cells were acquired at ϫ200 (Leica DMIL) and recorded on a host computer. From the pictures (10 random fields on 3 distinct coverslips for each treatment) we calculated the mean and SE of BrdU-immunoreactive (IR) cells. The experiments were done in duplicate. Finally, cell cycle distribution was assessed by washing with PBS and incubating for 30 min at 37°C at a density of 10 6 cells per milliliter of solution containing 250 mg of Na-citrate, 5 mg/ml RNase, 750 l of Nonidet P-40, and 16.5 mg of propidium iodide dissolved in 200 ml of deionized H2O. After a wash in PBS, 10 6 cells resuspended in 1 ml of PBS were scanned with a Beckman Epics-XL Coulter cytofluorimeter interfaced to a PC. The experiments were done in duplicate.
Immunocytochemistry for myosin heavy chain proteins. C2C12 myoblasts were seeded on glass coverslips at 6,000 cells/cm in DM (DMEM with 2% HS, L-glutamine, and antibiotics as described in Cell culture) and allowed to differentiate for 1-4 days. The cells were washed twice with PBS and fixed with 95% ethanol for 5 min at RT. After two washes with PBS, the cells were treated with 2% fetal calf serum in PBS for 30 min at 37°C. The samples were then incubated with 1:50 monoclonal mouse anti-myosin heavy chain antibody (MF20, Hybridoma Bank) in PBS for 90 min at 37°C, washed three times with PBS, and incubated with 1:200 anti-mouse secondary antibody (mouse immunoglobulin biotin, DAKO no. E0354) in PBS for 40 min at RT. After three further washes with PBS (5 min each at RT) we amplified the signal, and the staining was revealed as described in the StreptABComplex/HRP instructions (DAKO no. K0377; see also Cell proliferation assays). The pictures of the cells were acquired and stored as described above. The percentage (mean Ϯ SE) of MF20-IR cells was calculated from the stored pictures by inspecting 10 random fields on three distinct coverslips. The experiments were done in duplicate. Statistical analysis of the data was carried out with Student's paired t-test derived from Prism 2.0 software (GraphPad Software, San Diego, CA). -activated K ϩ currents were recorded from C 2 C 12 myoblasts on application of the Ca 2ϩ -mobilizing agent ionomycin (Fig. 1) . On myoblasts in the perforated-patch configuration, bathed in PSS and with no applied potential, ionomycin (0.5 M) evoked transient outward currents with mean peak current density of 26.2 Ϯ 3.7 pA/pF (n ϭ 10; Fig. 1, A and B) . Measurements of the reversal potential of the ionomycin-induced current were used to assess its selectivity. Voltage ramps from Ϫ150 to ϩ150 mV were applied during the ionomycin-induced response, and the reversal potential of the current was determined as the voltage at which the current traces under control conditions and in the presence of ionomycin intersected (Fig. 1A, inset) . The mean reversal potential was Ϫ87 Ϯ 4 mV (n ϭ 3), a value close to the K ϩ equilibrium potential for our recording conditions (E K ϭ Ϫ90 mV, calculated from the Nernst relationship). Ionomycin application shifted the zero-current potential from Ϫ26 Ϯ 5 to Ϫ63 Ϯ 9 mV (n ϭ 3). These results indicate that C 2 C 12 myoblasts possess a Ca 2ϩ -activated K ϩ current. The time course of the ionomycin-evoked outward current was transient, reverting to near-control values within 100 -200 s (Fig. 1A) . A transient time course was previously reported for the macroscopic IK Ca current, this behavior being ascribed to a Ca 2ϩ -dependent rundown process of the IK Ca channel (9, 18 ]. The effect of ionomycin-induced [Ca 2ϩ ] i increase was also investigated at the single-channel level, in the cell-attached configuration, with 150 mM K ϩ solution in the pipette. No single-channel activity could be detected in the absence of ionomycin (control conditions) at the resting membrane potential (0 mV applied potential; Fig. 1C ). Ionomycin (0.5 M) activated a single-channel activity in four of the five patches examined, the mean unitary current being Ϫ2.24 Ϯ 0.14 pA (at 0 mV applied potential; n ϭ 4). With a mean zero-current potential of Ϫ63 mV, as obtained in the presence of ionomycin (see above), a single-channel conductance of ϳ35 pS results. In accordance with the macroscopic current, the ionomycinactivated unitary current response was transient, with singlechannel activity ceasing after 50 -250 s, suggesting that the macroscopic current is underpinned by this unitary activity (Fig. 1C) . The results from Fig. 1 , namely Ca 2ϩ dependence, K ϩ selectivity, and small unitary current, provide compelling evidence to identify the ionomycin-activated current as sustained by either the SK Ca or the IK Ca channel.
RESULTS

Intracellular
Coapplication of the SK Ca /IK Ca channel activator DCEBIO (30) together with ionomycin activated a stable K ϩ current that displayed pharmacological properties congruent with the IK Ca current (Fig. 2) . A typical experiment illustrating the effects of coapplication of DCEBIO (100 M) and ionomycin (0.5 M) to a C 2 C 12 myoblast in the perforated-patch configuration is presented in Fig. 2A . Individual data points in Fig. 2A represent the current assessed at 0 mV with the ramp protocol stimulation under control conditions and after application of DCE-BIO ϩ ionomycin and CTL (2 M; in the continuous presence of DCEBIO ϩ ionomycin; see Fig. 2B, inset) . The average current obtained from 11 such experiments was 28.4 Ϯ 8.2 pA/pF at 0 mV (n ϭ 11). Figure 2B illustrates the results of the pharmacological test, showing that the DCEBIO ϩ ionomycinactivated K ϩ current was insensitive to either TEA (1 mM) or D-TC (300 M), indicating that neither SK2/SK3 nor BK Ca channels underlie this current. In contrast, the DCEBIO ϩ ionomycin-activated K ϩ current was markedly inhibited by CTX (200 nM), CTL (2 M), and the newly identified IK Ca channel antagonist NPPB (300 M; see Ref. 4) , suggesting that it was sustained by IK Ca channels. Figure 2C shows that the ionomycin-activated current block by both CTL and CTX was dose dependent. Fit of the data with the Hill relationship gave an IC 50 of 23.7 nM for CTX and 631 nM for CTL (Fig. 2C) . The ionomycin-activated K ϩ current displayed the same pharmacological properties as the DCEBIO ϩ ionomycin-activated K ϩ current (data not shown), indicating that combined DCEBIO ϩ ionomycin activates the same current activated by ionomycin alone. No significant change of the holding current (measured at 0 mV) was recorded after 10-min CTX incubation [holding current density was 2.5 Ϯ 0.4 pA/pF in control myoblasts (n ϭ 10) and 3.3 Ϯ 0.8 pA/pF in the presence of 200 nM CTX (n ϭ 5)]. These results suggest that the IK Ca channels in C 2 C 12 myoblasts have a low basal activity under our recording conditions.
Biophysical properties of IK Ca channel in C 2 C 12 myoblasts. The biophysical properties of the IK Ca channel were studied in inside-out patches under symmetrical 150 mM K ϩ conditions on activation with varying [Ca 2ϩ ] i (0.1-10 M). Under these conditions a single-channel activity similar in kinetics and conductance to that shown in Fig. 3A was often observed. The current-voltage (I-V) relationship constructed with a double Gaussian fit of the current amplitude histograms revealed a moderate inward rectification and a mean single-channel conductance of 38 Ϯ 6 pS (n ϭ 4), as assessed by linear fit of the I-V data at negative voltages (see Fig. 3B ). When internal K ϩ was substituted for Na ϩ , the single-channel current became inwardly directed at all voltages examined (Fig. 3B) , suggesting a high selectivity for K ϩ vs. Na ϩ (P Na /P K Ͻ 0.043, as estimated from the GHK relationship). We also assessed the voltage dependence of channel activity. The channel open probability (P o ) was assessed from the individual current traces by double Gaussian fits of corresponding amplitude histograms, and quantitative analysis was carried out by constructing a P o vs. voltage plot. As shown in Fig. 3B , inset, the channel P o did not vary appreciably for membrane potentials over the range of Ϫ100 to ϩ80 mV, suggesting that this channel is not gated by voltage.
The The number of functional IK Ca channels on C 2 C 12 myoblasts was estimated by applying noise analysis to the inactivation phase of the ionomycin-induced macroscopic currents similar to that shown in Fig. 1A . Variance ( 2 ) and mean current (I m ) of the ionomycin-induced macroscopic current were assessed for each adjacent 100-ms interval (Fig. 3E ). The resulting data were then fitted with the parabolic relationship 2 ϭ I m ⅐i Ϫ I m 2 /N, where i is single-channel current, which allowed an estimate of the total number of functional IK Ca channels (N) of the cell (Fig. 3F ). This analysis was performed on four cells, giving a mean number of functional IK Ca channels per cell of 8,722 Ϯ 1,132. Using the C m assessed for these cells (22.5 Ϯ 3.9 pF) and assuming a specific C m of 1 F/cm 2 (8), we calculated a mean IK Ca channel density of 3.9 Ϯ 0.7 channels/m 2 . IK Ca channel in C 2 C 12 myoblasts responds to ATP. We then tested whether the IK Ca channel in this cell line could be activated by a physiological stimulus such as ATP, given that previous studies demonstrated that this agonist is capable of releasing Ca 2ϩ from intracellular stores in C 2 C 12 myoblasts (5, 17). A brief Picospritzer-driven application of ATP (3 s, 100 M) on perforated myoblasts evoked, after a latency of several seconds (5-15 s), an outward current in 28 of the 55 cells tested. The current response took the form of either a single transient peak current (10 of 28; Fig. 4A , left) or current oscillations (15 of 28; Fig. 4A, right) . The remaining three current responses could not be classified. With regard to the single transient peak current responses (which we deal with in this study), these could be evoked by successive applications of the agonist and displayed amplitude and time course similar to those of the first application (cf. Fig. 4B ). To determine whether the ATP-induced transient outward current was a IK Ca current, the agonist was applied while the myoblast was being superfused with the IK Ca -specific inhibitor CTL (2 M). Under these conditions, no response to ATP was observed (cf. Fig.  4B , third ATP application; n ϭ 4). In two cells tested we found that pretreatment with CTX (200 nM) similarly prevented the ATP-induced response (data not shown). The ATP response was also absent after myoblast preincubation with the PLC inhibitor U-73122 (10 M, 10 min; data not shown), indicating the involvement of inositol 1,4,5-trisphosphate-sensitive intracellular Ca 2ϩ stores in the ATP-activated metabotropic cascade (13) . Analysis of the ATP response at the single-channel level (cell attached) confirmed that the IK Ca channel underlies this response. Cell-attached patches (with 150 mM K ϩ in the pipette, PSS in the bath, and no applied voltage) were subjected to brief Picospritzer-driven pulses of ATP (3 s, 100 M). This protocol evoked transient, unitary inward currents after a delay of several seconds, which had a time course similar to that of the ATP-induced macroscopic currents shown in Fig. 4, A and  B (cf. Fig. 4C ). Reapplication of the agonist normally evoked a second transient unitary current episode similar to the first episode. In contrast, the response was absent when ATP was applied in the presence of the IK Ca channel inhibitor CTL (2 M; data not shown). The ATP-induced unitary current had an average amplitude (estimated from amplitude histograms) of ϳ3.5 pA, as expected for IK Ca channels at a V m,patch of approximately Ϫ110 mV (i.e., V m,patch ϭ V pipette ϩ V m,cell ; see METHODS for details).
We then evaluated the effect of ATP-induced IK Ca channel activation on V m . Brief applications of ATP (3 s, 100 M) to perforated myoblasts under current-clamp recording conditions induced, after a short delay, a large, transient hyperpolarization (cf. Fig. 4D ) that had a mean value of ϳ35 mV (n ϭ 8; Fig.  4E ). The ATP-evoked hyperpolarizations closely matched the evoked transient currents we observed under voltage-clamp conditions, with regard to both the time course and latency of the response. The correspondence of the membrane voltage and current responses extended to the repeatability of the ATP-induced hyperpolarizations with successive applications (data not shown).
IK Ca channel is downregulated during myogenesis. In the engineered myogenic-like model C3H10T1/2-MRF4, it has been demonstrated that IK Ca channels are downregulated during myogenesis and downregulation was prevented by the myogenesis-suppressing agents bFGF and transforming growth factor (24, 25) . We have tested whether these findings apply to our myogenic model, i.e., whether myogenic progression in C 2 C 12 myoblasts would likewise be paralleled by downregulation of the IK Ca channel, and whether preventing myogenesis would prevent the IK Ca channel downregulation. ( 2 ) values assessed from the inactivating portion of the current recording shown in Fig. 1A . Im and 2 were estimated from 100-ms segments of the ionomycin-activated current traces, and the Im and 2 of the current trace before addition of ionomycin were subtracted from the assessed values. F: 2 vs. Im plot obtained from a perforated-patch recording at 0 mV of applied potential, with the IKCa current being stimulated by bath addition of 0.5 M ionomycin (cf. Fig. 1 ). Solid line represents the best fit of the experimental data with the parabolic relationship 2 ϭ Im ⅐ i Ϫ I m 2 /N, where i is the single-channel current and N is the total number of functional channels; i and N assessed for this cell were 0.12 pA and 10,728, respectively. Differentiation of C 2 C 12 myoblasts was induced by plating the cells in DM for 1-4 days. The induction of the myogenic program was confirmed by a marked increase in the percentage of IR myoblasts for the myosin heavy chain (Fig. 5C ). In line with previous data, we found that IK Ca current amplitude decreased during myogenesis induced by serum withdrawal (Fig. 5, A and B) . Figure 5A illustrates representative DCEBIO ϩ ionomycin-activated IK Ca currents from C 2 C 12 myoblasts kept in DM for either 1 or 4 days. As shown in Fig.  5B , the decrease in IK Ca current usually started 24 -48 h after myoblasts had been placed in DM, and after 4 days the IK Ca current had decreased on average by ϳ90%, compared with control myoblasts kept in GM. When bFGF was added to the DM to prevent myogenesis, downregulation was likewise removed, with the IK Ca current remaining stable in amplitude at the levels found in myoblasts kept in GM (Fig. 5B) . Previous reports showed that myoblasts placed in differentiation medium start expressing the DRK current, which is absent in myoblasts kept in growth medium (14) . We monitored the DRK current in C 2 C 12 myoblasts (kept in DM) over the time range in which the IK Ca current was downregulated. We found that the DRK current, absent at day 1 in DM, normally appeared after 48 -72 h, and at day 4 it reached a mean amplitude of 22.5 Ϯ 8.8 pA/pF (Fig. 5C ). Figure 5D illustrates representative DRK current families activated by depolarizing pulses, in DM at day 1 and day 4. Notably, no DRK current was ever observed in GM, regardless of the time for which myoblasts were kept in culture. The upregulation of the DRK current thus seems to correlate inversely with the downregulation of the IK Ca current (cf. Fig. 5C , taken from the DM data of Fig. 5B) .
In C3H10T1/2 cells transfected with the muscle regulatory factor MRF4, and thereby capable of being induced toward a myoblastic lineage, the IK Ca channel has been shown to be instrumental for promoting cell proliferation induced by bFGF (25) . We therefore assessed whether the IK Ca channel has a role on the proliferation of C 2 C 12 myoblasts. Cells were maintained in either DM or DM ϩ bFGF, and incubated for up to 48 h with saturating concentrations of the IK Ca channel blocker CTX (200 nM). In both conditions used, CTX did not affect the percentage of viable cells with respect to control (no CTX), as assayed with the MTT method (Fig. 6A) . Because of its toxicity The bath solution perfusing the myoblast was PSS, the pipette solution contained 170 mM K ϩ as main salt, and the holding potential was 0 mV. B: IKCa current vs. days in culture from C2C12 myoblasts kept in differentiation medium (DM; n ϭ 7), growth medium (GM; n ϭ 7), or DM ϩ basic FGF (bFGF, 4 days; n ϭ 4). IKCa current amplitude was estimated as CTL-sensitive current from experiments similar to that shown in A. C: delayed-rectifier Kϩ (DRK) current density vs. days in DM. DRK current density was estimated as the current activated by a 100-ms-long depolarizing pulse to ϩ40 mV, from a holding potential of Ϫ60 mV, divided by the membrane capacitance. to myoblasts on long exposure, CTL could not be used for these tests (data not shown). In contrast, treatment of C 2 C 12 myoblasts with the src kinase inhibitor PP-2 (50 M) was found to be effective in reducing cell proliferation under the same culture conditions (Fig. 6B ), in line with previous studies (28) . The lack of an antiproliferative effect of CTX on bFGFinduced C 2 C 12 myoblast growth was confirmed by BrdU incorporation experiments (data not shown). (25) . IK Ca channel is downregulated during myogenesis. Ion channels are centrally involved in myogenesis, with several types being either upregulated or downregulated during differentiation. A major finding of this study is that the induction of differentiation by serum withdrawal results in downregulation of IK Ca channel expression. In myoblasts placed in DM, the IK Ca current decrease could be observed after 24 -48 h, and by day 4 IK Ca current had dropped below 10% of its value in control myoblasts (i.e., myoblasts kept in GM). When bFGF, a growth factor shown to prevent myogenesis, was added to the DM, the downregulation of the IK Ca current was likewise prevented (Fig. 5B) . These results, consistent with previous reports for the C3H10T1/2-MRF4 myogenic cell line (24) , indicate that IK Ca channel expression is modulated by a regulatory signaling pathway that also controls cell differentiation. This could be the bFGF receptor tyrosine kinase superfamily and its downstream signaling cascade, primarily involving the activation of the Ras/Raf/MEK/ERK pathway, as reported in another myogenic model (24) .
DISCUSSION
Expression of IK
During human myoblast differentiation a specific sequential expression of K ϩ currents [i.e., the ether-à-go-go (eag) and K ir currents] has been reported to be critical for myogenic progression and acquisition of cell excitability (1). Other K ϩ currents, including the DRK current, were shown to appear 24 h after C 2 C 12 myoblasts had been placed in differentiation medium (14) . We found that the DRK current, absent in myoblasts kept in GM, begins to appear after serum withdrawal, at about the same time the IK Ca current starts to decrease. These results may indicate that the expressions of these two currents are sequentially ordered during myogenesis of the C 2 C 12 cell line, although a causal link between these two currents has not been established. With regard to IK Ca channel downregulation during myoblast differentiation, it is worthy of note that another current, I Cl,sw , has been reported to disappear with a similar time course (33) . The functional meaning, if any, of this simultaneous downregulation is likewise unknown. However, because these two currents (IK Ca current and I Cl,sw ) are coexpressed in many cell models and coactivated in several important cellular processes including volume regulation (where their combined action mediates KCl efflux), their parallel downregulation may lead to inhibition of those processes that depend on cell volume changes, such as cell motility (21, 29, 36) .
Functional role of IK Ca channel in C 2 C 12 myoblasts. It has been shown that IK Ca channel activity is essential for bFGFsustained myoblast proliferation in the C3H10T1/2-MFR4 cell line (25) . We therefore tested whether the IK Ca current is also instrumental for sustaining cell proliferation in C 2 C 12 myoblasts (6, 22, 25, 31) . To this end, we used the IK Ca channel inhibitor CTX (200 nM), which did not show any effect on the growth rate of C 2 C 12 myoblasts (Fig. 6) , indicating that the IK Ca channel is not involved in this process. These observations allow us to conclude that the previously described modulatory role of IK Ca channels on C3H10T1/2-MFR4 cell proliferation (25) cannot be generalized to all myoblastic cell lines.
The lack of a CTX-sensitive holding current under our resting conditions indicates that the IK Ca channel does not contribute to the resting V m . This conclusion is consistent with the relatively low V m of this cell line (ϳϪ20 mV, cf. Fig. 4E ; also see Refs. 14, 33). We further showed that the IK Ca current can be activated by a physiological agent such as ATP that leads to an increase in intracellular Ca 2ϩ (5, 17) . Our results indicate that the ATP response occurs via a PLC-mediated Ca 2ϩ release from internal stores. The IK Ca current activation induced by ATP occurred in intact myoblasts (perforated and cell-attached configurations) and resulted in a membrane hyperpolarization of ϳ35 mV. As V m plays an important modulatory role in a number of cellular responses, by linking changes in intracellular Ca 2ϩ to V m the IK Ca channels may serve critical functions in several cellular processes of C 2 C 12 myoblasts, including myogenesis (12, 16, 20) .
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